MARKET

AEMD

AEMD

Aethlon Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.380
-0.120
-8.00%
Closed 19:48 10/28 EDT
OPEN
1.450
PREV CLOSE
1.500
HIGH
1.460
LOW
1.360
VOLUME
367.06K
TURNOVER
--
52 WEEK HIGH
4.860
52 WEEK LOW
0.7640
MARKET CAP
16.66M
P/E (TTM)
-0.7106
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Aethlon Medical Q2 EPS $(0.15) Up From $(1.29) YoY
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.15) per share. This is a 88.37 percent increase over losses of $(1.29) per share from the same period last year.
Benzinga · 11h ago
Aethlon Medical EPS misses by $0.03
Aethlon Medical (AEMD): FQ2 GAAP EPS of -$0.15 misses by $0.03.Cash balance of of $14.5M.Press Release
Seekingalpha · 11h ago
Aethlon Medical, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 28, 2020 / Aethlon Medical, Inc.
ACCESSWIRE · 12h ago
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 27)
Benzinga · 20h ago
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus.
Benzinga · 3d ago
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its second quarter fiscal year 2021, ended September 30, 2020, at 4:15 pm Eastern time on Wednesday, October 28, 2020.
PR Newswire · 10/19 12:01
PGEN, GME, APHA and FSLY among midday movers
Gainers: Staffing 360 Solutions (STAF) +86%.China HGS Real Estate (HGSH) +65%.Huttig Building Products (HBP) +39%.Dragon Victory International (LYL) +35%.SPI Energy (SPI) +30%.Organogenesis (ORGO) +20%.Armata Pharmaceuticals (ARMP) +20%.Cars.com (CARS) +18%.Precigen (PGEN) +17%.GameStop (GME) +16%.Losers: Kaixin Auto
Seekingalpha · 10/15 16:47
NIO, MDRX, SRNE and DVAX among midday movers
Gainers: Interpace Biosciences (IDXG) +41%.Allscripts Healthcare Solutions (MDRX) +31%.Replimune Group (REPL) +27%.VOXX International (VOXX) +25%.AnaptysBio (ANAB) +22%.NIO (NIO) +20%.OncoCyte (OCX) +20%.Panhandle Oil and Gas (PHX) +16%.RealNetworks (RNWK) +14%.Oblong (OBLG) +13%.Losers: Cyclerion Therapeutics
Seekingalpha · 10/14 16:38
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AEMD. Analyze the recent business situations of Aethlon Med through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AEMD stock price target is 13.00 with a high estimate of 13.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 29
Institutional Holdings: 557.46K
% Owned: 4.62%
Shares Outstanding: 12.07M
TypeInstitutionsShares
Increased
3
5.68K
New
7
7.48K
Decreased
4
3.08K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-3.82%
Healthcare Equipment & Supplies
-3.30%
Key Executives
Chairman/Independent Director
Charles Fisher
Chief Executive Officer/Director
Timothy Rodell
Chief Financial Officer/Senior Vice President - Finance/Secretary/IR Contact Officer
James Frakes
Independent Director
Edward Broenniman
Independent Director
Guy Cipriani
Independent Director
Sabrina Johnson
Independent Director
Chetan Shah
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AEMD
Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Aethlon Medical, Inc. stock information, including NASDAQ:AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.